These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytokine regulation of mucus production in a model of allergic asthma. Cohn L; Whittaker L; Niu N; Homer RJ Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding how interleukin 13 signals are involved in the pathogenesis of bronchial asthma. Izuhara K; Umeshita-Suyama R; Akaiwa M; Shirakawa T; Deichmann KA; Arima K; Hamasaki N; Hopkin JM Arch Immunol Ther Exp (Warsz); 2000; 48(6):505-12. PubMed ID: 11197605 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-13 in asthma. Wills-Karp M; Chiaramonte M Curr Opin Pulm Med; 2003 Jan; 9(1):21-7. PubMed ID: 12476080 [TBL] [Abstract][Full Text] [Related]
7. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. Doucet C; Brouty-Boyé D; Pottin-Clémenceau C; Canonica GW; Jasmin C; Azzarone B J Clin Invest; 1998 May; 101(10):2129-39. PubMed ID: 9593769 [TBL] [Abstract][Full Text] [Related]
8. [Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases]. Izuhara K Rinsho Byori; 2001 Apr; 49(4):360-4. PubMed ID: 11391949 [TBL] [Abstract][Full Text] [Related]
9. Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Ralpha-independent airway hyperreactivity. Webb DC; Mahalingam S; Cai Y; Matthaei KI; Donaldson DD; Foster PS Eur J Immunol; 2003 Dec; 33(12):3377-85. PubMed ID: 14635046 [TBL] [Abstract][Full Text] [Related]
14. Role of IL-23-Th17 cell axis in allergic airway inflammation. Wakashin H; Hirose K; Iwamoto I; Nakajima H Int Arch Allergy Immunol; 2009; 149 Suppl 1():108-12. PubMed ID: 19494515 [TBL] [Abstract][Full Text] [Related]
15. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. Ishikawa Y; Yoshimoto T; Nakanishi K Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648 [TBL] [Abstract][Full Text] [Related]
16. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. Mitchell J; Dimov V; Townley RG Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598 [TBL] [Abstract][Full Text] [Related]
18. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Wang IM; Lin H; Goldman SJ; Kobayashi M Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459 [TBL] [Abstract][Full Text] [Related]
19. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes. Wong CK; Li PW; Lam CW Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653 [TBL] [Abstract][Full Text] [Related]
20. New advances in the pathogenesis and therapy of bronchial asthma. Ricci M; Matucci A; Rossi O Ann Ital Med Int; 1998; 13(2):93-110. PubMed ID: 9734142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]